Matthew Gubens

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    AstraZeneca
    Topic:
    ad board/consulting
    Date added:
    01/12/2023
    Date updated:
    04/19/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    BMS
    Topic:
    ad board/consulting
    Date added:
    01/12/2023
    Date updated:
    04/19/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Cardinal Health
    Topic:
    ad board/consulting
    Date added:
    01/12/2023
    Date updated:
    04/19/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Genentech/Roche
    Topic:
    ad board/consulting
    Date added:
    01/12/2023
    Date updated:
    04/19/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Gemzyme
    Topic:
    ad board/consulting
    Date added:
    01/12/2023
    Date updated:
    04/19/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Guardant
    Topic:
    ad board/consulting
    Date added:
    01/12/2023
    Date updated:
    04/19/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    iTeos
    Topic:
    ad board/consulting
    Date added:
    01/12/2023
    Date updated:
    04/19/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Sanofi
    Topic:
    ad board/consulting
    Date added:
    01/12/2023
    Date updated:
    04/19/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Surface
    Topic:
    ad board/consulting
    Date added:
    01/12/2023
    Date updated:
    04/19/2024
Return to 2024 Napa Valley Lung Cancer Conference